{
    "clinical_study": {
        "@rank": "126274", 
        "brief_summary": {
            "textblock": "This study will evaluate patients with inflammatory forms of arthritis within the first year\n      of onset.  The study will attempt to clarify factors that may predict disease course such as\n      evolution into rheumatoid arthritis (RA) or other chronic inflammatory arthropathies.\n      Synovial biopsies and synovial fluid will be obtained to search for microbial agents and\n      other initiating and modulating factors that may be most readily distinguished early in the\n      disease and to determine the stage of disease at which certain immunologic and hormonal\n      changes become evident.  The study will also search for genetic and other features that may\n      be associated with specific forms of inflammatory arthropathies that might predict the\n      subsequent clinical disease course or response to different agents used in treatment of RA,\n      Reiter's syndrome and other types of chronic inflammatory arthropathies."
        }, 
        "brief_title": "The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis", 
        "completion_date": "June 2000", 
        "condition": [
            "Arthritis", 
            "Arthritis, Reactive", 
            "Arthritis, Rheumatoid", 
            "Reiter's Disease", 
            "Synovitis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid", 
                "Arthritis, Reactive", 
                "Synovitis"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study will evaluate patients with inflammatory forms of arthritis within the first year\n      of onset.  The study will attempt to clarify factors that may predict disease course such as\n      evolution into rheumatoid arthritis (RA) or other chronic inflammatory arthropathies.\n      Synovial biopsies and synovial fluid will be obtained to search for microbial agents and\n      other initiating and modulating factors that may be most readily distinguished early in the\n      disease and to determine the stage of disease at which certain immunologic and hormonal\n      changes become evident.  The study will also search for genetic and other features that may\n      be associated with specific forms of inflammatory arthropathies that might predict the\n      subsequent clinical disease course or response to different agents used in treatment of RA,\n      Reiter's syndrome and other types of chronic inflammatory arthropathies."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Patients to be studied will be required to have an inflammatory arthritis of less than one\n        year's duration.\n\n        Patients must be greater than 18 years of age.\n\n        Pregnant patients may be entered into the study, but they will not undergo percutaneous\n        needle biopsy or joint radiographs.\n\n        No patients with known bacterial septic arthritis, crystal-induced, or degenerative\n        arthritis.\n\n        Synovial biopsies will not be performed if patients have platelet counts less than\n        70,000/mm(3), other bleeding diathesis in the skin over the joint or sepsis.\n\n        Joint MRI:  Patient must currently be evaluated at the NIH through protocol 94-AR-0194 or\n        98-AR-0150.\n\n        Joint MRI:  Patient must have at least one clinically active arthritic joint that is under\n        consideration for percutaneous needle synovial biopsy.\n\n        Joint MRI:  Patients must not have the following:  cardiac pacemakers, auto\n        defibrillators, neural stimulators, aneurysm clips, metallic prostheses, cochlear (ear)\n        implants, any implanted devices (pumps, infusion devices, etc.), metal fragments in the\n        eye, or shrapnel injuries.\n\n        Joint MRI:  Patients must not exceed the size limitations of the MRI scanner.\n\n        Joint MRI:  Must not suffer from claustrophobia.\n\n        Joint MRI:  Must not have had a previous anaphylactoid reaction to gadolinium-based\n        contrast material.\n\n        Joint MRI:  Must not be pregnant."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "500", 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001375", 
            "org_study_id": "940194", 
            "secondary_id": "94-AR-0194"
        }, 
        "keyword": [
            "Infection", 
            "Reactive Arthritis", 
            "Rheumatoid Arthritis", 
            "Synovial Biopsy", 
            "Synovial Fluid", 
            "Synovitis"
        ], 
        "lastchanged_date": "March 3, 2008", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "9154645", 
                "citation": "Kotake S, Schumacher HR Jr, Yarboro CH, Arayssi TK, Pando JA, Kanik KS, Gourley MF, Klippel JH, Wilder RL. In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis. Proc Assoc Am Physicians. 1997 May;109(3):286-301."
            }, 
            {
                "PMID": "9458197", 
                "citation": "Kanik KS, Hagiwara E, Yarboro CH, Schumacher HR, Wilder RL, Klinman DM. Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. J Rheumatol. 1998 Jan;25(1):16-22."
            }, 
            {
                "PMID": "4117789", 
                "citation": "Schumacher HR, Kitridou RC. Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum. 1972 Sep-Oct;15(5):465-85. No abstract available."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001375"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "August 1994", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "August 1999"
    }, 
    "geocoordinates": {
        "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)": "38.985 -77.095"
    }
}